Related Experiment Video
Updated: Jan 17, 2026

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Addressing discrepancies in symptom and psychosocial assessments in hypertrophic cardiomyopathy
Brijesh Sathian1, Abdalla Fadul1, Yasir Alabbas1
1Geriatrics and Long-term Care Department, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Abstract:
This correspondence critiques a 2025 study by Tsenov et al. on hypertrophic cardiomyopathy, highlighting discrepancies in reported symptom burden, psychological support, employment impact, diagnostic delays, activity restrictions, and medication tolerability. Recent evidence suggests improved outcomes with novel therapies and integrated care, challenging the study's conclusions. We advocate for reconciled analyses and future longitudinal studies to enhance patient-centered hypertrophic cardiomyopathy management.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Cardiomyopathy VI: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

